Intercure (INCR) AI Stock Analysis

Intercure

(NASDAQ:INCR)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue RecoveryThe return to revenue growth indicates renewed demand for InterCure’s medical cannabis products after two weaker years. If sustained, improving sales can support greater operating scale, strengthen distribution economics, and provide a foundation for restoring profitability over the next several quarters.

Negative Factors

Persistent Net LossesInterCure has not yet converted its revenue base into sustained net profitability, despite the 2025 sales recovery and narrower losses. Continued losses can consume equity, limit internally funded expansion, and leave the business more exposed if revenue growth does not translate into stronger earnings.

Intercure (INCR) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $155.06M
Dividend Yield: ―
Average Volume (3M): 22.73K
Price to Earnings (P/E): -4.0
Beta (1Y): 0.62
Revenue Growth: ―
EPS Growth: ―
Country: US
Employees: 285
Sector: General
Sector Strength: 55
Industry: Drug Manufacturers - Specialty & Generic

Intercure Business Overview & Revenue Model

Company Description

InterCure Ltd., alongside its affiliated companies, is actively involved in the medical cannabis industry, operating both domestically in Israel and internationally. Their activities encompass the entire spectrum from research and cultivation to prod...

Intercure Risk Analysis

Intercure disclosed 68 risk factors in its most recent earnings report. Intercure reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Intercure Peers Comparison

Overall Rating

Financial Indicators

INCR against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%

* General Sector Average

Performance Comparison

INCR and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
INCR	Intercure	4.05	-2.85	-41.30%
IL:TGTR	Together Pharma Ltd.	187.90	-129.60	-40.82%
IL:CNZN.M	Canzon-M	89.90	-11.90	-11.69%
IL:SEMG	Seach Medical Group Ltd.	261.50	-0.97	-0.37%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Intercure AI Stock Analysis